North America trade pact deals rare setback to big pharma

19 December 2019 - A revamped North American trade deal nearing passage in Congress gives both the White House and ...

Read more →

Biosimilar stakeholders praise removal of biologic exclusivity provisions from USMCA

11 December 2019 - An agreement on the United States–Mexico–Canada Agreement, a trade deal that updates the North American Free ...

Read more →

US pharma companies really do want Britain to pay more for drugs

6 December 2019 - When President Donald Trump arrived in the United Kingdom this week, he landed bang in the ...

Read more →

Donald Trump says US would never take over any part of Britain’s NHS

3 December 2019 - US President Donald Trump has reassured the British public that even if the National Health Service ...

Read more →

NHS and drug prices could be included in US-UK trade deal, leaked documents suggest

27 November 2019 - The NHS and drug patents have been part of ongoing post-Brexit trade negotiations between the US ...

Read more →

Labour will exclude the NHS and medicines from trade deals with the US

17 November 2019 - Donald Trump wants the big US pharmaceutical companies to get its hands on our public services – ...

Read more →

NHS bill for US drugs 'could soar under post-Brexit trade deal'

28 October 2019 - Dispatches investigation finds 'drug pricing' has been discussed in six initial meetings between trade officials from the ...

Read more →

UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks

29 October 2019 - Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’. ...

Read more →

Trade agreement drug monopoly is obsolete given faster, better drug discovery

2 October 2019 - For decades, the brand-name drug industry has relentlessly promoted the message that any reduction in its ...

Read more →

Institutional investors urging Congress to vote down CUSMA, citing effect on drug prices

23 September 2019 - A group of institutional investors representing more than US$500 billion is calling on the U.S. Congress ...

Read more →

ABPI position on US trade deal and medicines pricing

21 August 2019 - In response to concerns about the impact a US trade deal would have on medicine pricing, ...

Read more →

NICE to be sovereign: U.K. rejects Trump suggestion to include NHS in possible trade deal

18 June 2019 - In the face of the increasing odds of a hard Brexit, and the prospect of the ...

Read more →

Not playing NICE: UK drugs gatekeeper in US crosshairs

10 June 2019 - The U.S. wants Britain to buy more of its drugs after Brexit — but it also ...

Read more →

Could the NHS be part of a US-UK trade deal?

5 June 2019 - Donald Trump sparked concern about the health service’s future but the reality is more complex. ...

Read more →

Trump says UK’s National Health Service not on table in trade talks

5 June 2019 - ‘When you’re dealing in trade everything’s on the table, so NHS or anything else,’ US president said ...

Read more →